Aquestive Therapeutics, Inc.

The current price of AQST is 4.50 USD — it has increased by 14.80% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aquestive Therapeutics, Inc. stocks are traded under the ticker AQST.

Aquestive Therapeutics, Inc. is going to release the next earnings report on Apr 30, 2024. Keep track of upcoming events with our Earnings Calendar.

AQST stock is 15.01% volatile and has beta coefficient of 0.38. Check out the list of the most volatile stocks — is Aquestive Therapeutics, Inc. there?

One year price forecast for Aquestive Therapeutics, Inc. has a max estimate of 12.00 USD and a min estimate of 7.00 USD.

AQST earnings for the last quarter are −0.03 USD whereas the estimation was −0.11 USD which accounts for 73.53% surprise. Estimated earnings for the next quarter are −0.09 USD. See more details about Aquestive Therapeutics, Inc. earnings.

Aquestive Therapeutics, Inc. revenue for the last quarter amounts to ‪13.00 M‬ USD despite the estimated figure of ‪11.51 M‬ USD. In the next quarter revenue is expected to reach ‪11.66 M‬ USD.

Yes, you can track Aquestive Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

AQST net income for the last quarter is ‪−8.11 M‬ USD, while the quarter before that showed ‪−2.04 M‬ USD of net income which accounts for −298.57% change. Track more Aquestive Therapeutics, Inc. financial stats to get the full picture.

Today Aquestive Therapeutics, Inc. has the market capitalization of ‪352.67 M‬, it has decreased by 1.69% over the last week.

No, AQST doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, AQST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aquestive Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

AQST reached its all-time high on Sep 13, 2018 with the price of 20.70 USD, and its all-time low was 0.62 USD and was reached on Jul 1, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 19, 2024, the company has 135.00 employees. See our rating of the largest employees — is Aquestive Therapeutics, Inc. on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aquestive Therapeutics, Inc. technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aquestive Therapeutics, Inc. stock shows the buy signal. See more of Aquestive Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on Aquestive Therapeutics, Inc. future price: according to them, AQST price has a max estimate of 12.00 USD and a min estimate of 7.00 USD. Read a more detailed Aquestive Therapeutics, Inc. forecast: see what analysts think of Aquestive Therapeutics, Inc. and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Aquestive Therapeutics, Inc. EBITDA is ‪−13.76 M‬ USD, and current EBITDA margin is −26.77%. See more stats in Aquestive Therapeutics, Inc. financial statements.